Anti-TNF-alpha-Therapie bei anderen Indikationen

M. Bernateck

doi:10.1055/s-0037-1620168

Arthritis und Rheuma, Table of Contents

Arthritis und Rheuma 2009; 29(04): 223-229
DOI: 10.1055/s-0037-1620168

Biologika in der Rheumatologie – zehn Jahre Anti-TNF-Therapie

Schattauer GmbH

Anti-TNF-alpha-Therapie bei anderen Indikationen

Erfahrungen bei CRPS und chronischer HerzinsuffizienzOther indications for anti-TNF-alpha treatment – experience with CRPS and chronic heart failure

M. Bernateck

¹Klinik für Anästhesiologie und Intensivmedizin, Interdisziplinäre Schmerzambulanz, Medizinische Hochschule Hannover

› Author Affiliations

Abstract

PDF Download

Zusammenfassung

Das Komplexe Regionale Schmerzsyndrom (CRPS) ist eine häufige Komplikation nach Traumen oder elektiven Eingriffen zumeist an der oberen Extremität mit einer Prävalenz von etwa 30 pro 100 000. Prospektive Studien von Patienten mit distaler Radiusfraktur ermittel-ten eine Inzidenz von mehr als 20 Prozent dieser Komplikation. Aktuell unterscheiden die Diagnose-Kriterien zwischen CRPS ohne (CRPS Typ 1) und CRPS mit Nervenläsion (CRPS Typ 2). Zytokine, wie z. B. Tumor-Nekrose-Faktor alpha (TNF-alpha) scheinen eine wichtige Rolle bei der Mediation von mechanischer Hyperalgesie und der Ödembildung in der akuten Phase des CRPS Typ 1 zu spielen. Die Erkenntnis dieser Zusammenhänge führte zu ersten erfolgreichen Einsätzen von Anti-TNF-alpha-Inhibitoren bei Patienten mit CRPS Typ 1.

Summary

Complex Regional Pain Syndrome (CRPS) is a frequent complication after trauma or operation with a prevalence of about 30 per 100,000. Prospective studies in patients with distal radial fracture revealed a more than 20 % incidence of this complication. Current diagnostic guidelines distinguish between CRPS without (CRPS type 1) or with obvious nerve lesion (CRPS type 2). Cytokines, particularly tumor necrosis factor (TNF)-alpha, seem to play an important role in the mediation of mechanical hyperalgesia in CRPS and other neuropathic pain syndromes. This understanding has led to successful treatment of early stage CRPS type 1 symptoms using systemic and local administration of TNF-alpha antibodies.

Schlüsselwörter

CRPS - TNF-alpha - mechanische Hyperalgesie

Keywords

CRPS - TNF-alpha - mechanical hyperalgesia

PDF (159 kb)

References

Literatur
1 Adami S. et al. Bisphosphonate therapy of eflex sympathetic dystrophy syndrome.. Ann Rheum Dis 1997; 56 (03) 201-204.
2 Birklein F, Riedl B, Claus D, Neundörfer B. Pattern of autonomic dysfunction in time course of complex regional pain syndrome.. Clin Auton Res 1998; 8 (02) 79-85.
3 Albazaz R. et al. Complex regional pain syndrome: a review.. Ann Vasc Surg 2008; 22 (02) 297-306.
4 Anker SD, Coats AJ. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH.. Int J Cardiol 2002; 86 (2-3) 123-130.
5 Bernateck M. et al. Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1.. Anesth Analg 2007; 105 (04) 1148-1151.
6 Birklein F. et al. Pattern of autonomic dysfunction in time course of complex regional pain syndrome.. Clin Aton Res 1998; 8 (02) 79-85.
7 Birklein F. et al. Neurological findings in complex regional pain syndromes – analysis of 145 cases.. Acta Neurol Scand 2000; 101 (04) 262-269.
8 Birklein F. et al. Sudomotor function in sympathetic reflex dystrophy.. Pain 1997; 69 (02) 49-54.
9 Bonica J. Causalgia and other reflex dystrophies.. In Bonica JJ. ed. The management of pain, second ed Philadelphia: Lea & Felbiger; 1990
10 Braus DF. et al. The shoulder-hand syndrome after stroke: a prospective clinical trial.. Ann Neurol 1994; 36 (05) 728-733.
11 Bruehl S. et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain.. Pain 1999; 81 (1-2) 147-154.
12 Christensen K. et al. The reflex dystrophy syndrome response to treatment with systemic corticosteroids.. Acta Chir Scand 1982; 148 (08) 653-655.
13 Cutolo M. et al. Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside.. Ann Rheum Dis 2008; 67 (07) 905-908.
14 de Mos M. et al. Current understandings on complex regional pain syndrome.. Pain Pract 2009; 9 (02) 86-99.
15 Doupe J. Post-traumatic pain and the causalgic syndromes.. J Neurol Neurosurg Psychiatry 1944; 7: 33-48.
16 Dworkin RH. et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.. Arch Neurol 2003; 60 (11) 1524-1534.
17 Eberle T. et al. Warm and cold complex regional pain syndromes: differences beyond skin temperature?. Neurology 2009; 72 (06) 505-512.
18 Evans J. Reflex sympathetic dystrophy.. Surg Clin North Am 1946; 26: 435-448.
19 Förderreuther S. et al Impaired self-perception of the hand in complex regional pain syndrome (CRPS).. Pain 2004; 110 (03) 756-761.
20 Galer B, Jensen M. Neglect-like symptoms in complex regional pain syndrome: results of a self-administered survey.. J Pain Symptom Manage 1999; 18 (03) 213-217.
21 Geertzen J. et al Stressful life events and psychological dysfunction in complex regional pain syndrome Type 1.. Clin J Pain 1998; 14 (02) 143-147.
22 Genth-Zotz S. et al Immunactivation in chronic heart failure.. Inflammatory mediators. Z Kardiol 2004; 93 (Suppl. 04) 24-30.
23 Graif M. et al. Synovial effusion in reflex sympathetic dystrophy: an additional sign for diagnosis and staging.. Skeletal Radiol 1998; 27 (05) 262-265.
24 Gullestad L, Aukrust P. Review of trials in chronic heart failure showing broad- spectrum anti-inflammatory approaches.. Am J Cardiol 2005; 95 (11) 17C-23C. discussion 38C-40C
25 Huygen F. et al. Evidence for local inflammation in complex regional pain syndrome type 1.. Mediators Inflamm 2002; 11 (01) 47-51.
26 Huygen FJ. et al. Successful treatment of CRPS 1 with anti-TNF.. J Pain Symptom Manage 2004; 27 (02) 101-103.
27 Intenzo CM. et al. The role of nuclear medicine in the evaluation of complex regional pain syndrome type I.. Clin Nucl Med 2005; 30 (06) 400-407.
28 Kwon HJ. et al. Case reports of heart failure after therapy with a tumor necrosis factor antagonist.. Ann Intern Med 2003; 138 (10) 807-811.
29 Leriche R. De la causalgie envisageé comme une nevrite du sympathique et de son traitment par la denudation e l’excision des plexus nerveux periarteriels.. Presse Med 1916; 24: 178-180.
30 Levine B. et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.. N Engl J Med 1990; 323 (04) 236-241.
31 Livingston W. Pain mechanisms. A physiologic interpretation of causalgia and its related states.. New York: Macmillan; 1944
32 Lynch M. Psychological aspects of reflex sympathetic dystrophy: a review of the adult and paediatric literature.. Pain 1992; 49 (03) 337-347.
33 Maihofner C, Birklein F. Complex regional pain syndromes: new aspects on pathophysiology and therapy.. Fortschr Neurol Psychiatr 2007; 75 (06) 331-342.
34 Maihofner C. et al. Mechanical hyperalgesia in complex regional pain syndrome: a role for TNF-alpha?. Neurology 2005; 65 (02) 311-313.
35 Mitchell S. et al Gunshots wounds and other injuries of nerves.. New York: Lippincott JP; 1864
36 Sandroni P. et al. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study.. Pain 2003; 103 (1-2) 199-207.
37 Seifert F. et al. Differential endogenous pain modulation in complex-regional pain syndrome.. Brain 2009; 132: 788-800.
38 Stanton-Hicks M. et al. Reflex sympathetic dystrophy: changing concepts and taxonomy.. Pain 1995; 63 (01) 127-133.
39 Sudeck P. Über die akute entzündliche Knochenatrophie.. Arch Klin Chir 1900; 62: 147-156.
40 Sudeck P. Die so genannte akute Knochenatrophie als Entzündungsvorgang.. Der Chirurg 1942; 15: 449-457.
41 Uceyler N. et al. Differential expression patterns of cytokines in complex regional pain syndrome.. Pain 2007; 132 (1-2) 195-205.
42 van de Beek WJ. et al. Innate cytokine profile in patients with complex regional pain syndrome is normal.. Pain 2001; 91 (03) 259-261.
43 van Hilten B. et al. Multifocal or generalized tonic dystonia of complex regional pain syndrome: a distinct clinical entity associated with HLA-DR13.. Ann Neurol 2000; 48 (01) 113-116.
44 Veldman P. et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients.. Lancet 1993; 342 8878 1012-1016.
45 Wasner G. et al. Skin temperature side differences – a diagnostic tool for CRPS?. Pain 2002; 98 (02) 19-26.
46 Zyluk A. The usefulness of quantitative evaluation of three-phase scintigraphy in the diagnosis of post-traumatic reflex sympathetic dystrophy.. J Hand Surg 1999; 24: 16-21.